Visa Inc (V) Stock News

A class action lawsuit has been filed against AEVEX Corp. alleging that IPO offering documents were materially false and misleading. The complaint claims defendants pre-arranged a plan to waive lock-up restrictions and conduct a secondary offering that benefited the controlling private equity owner with $207.9 million while the company received no proceeds. Investors who purchased AEVEX stock during the IPO or between April 17 and June 4, 2026 are encouraged to join the case.

CB Financial Services (CBFV), a Pennsylvania-based bank holding company, offers an attractive dividend yield of 3.02% with an annualized dividend of $1.12, up 9.8% year-over-year. The company maintains a conservative 37% payout ratio and expects solid earnings growth with a 2026 consensus estimate of $3.21 per share, representing 18.45% year-over-year growth. CBFV holds a Zacks Rank #2 (Buy) rating, making it a compelling investment opportunity for income investors.

Ventas, a Chicago-based Finance/REIT stock, is presented as a strong dividend play with a current yield of 2.26% and an annualized dividend of $2.08, up 8.3% year-over-year. The company expects solid earnings growth with a 2026 consensus estimate of $3.89 per share (11.78% growth) and maintains a sustainable 57% payout ratio. Despite holding a Zacks Rank #3 (Hold) rating, the stock is positioned as a compelling opportunity for income investors.

Univest (UVSP), a Northeast-based finance company, is highlighted as an attractive dividend play for income investors. The company offers a 2.24% dividend yield with a 5.7% year-over-year increase in annualized dividends. With a low 27% payout ratio and solid earnings growth projected at 17.25% for 2026, UVSP carries a Zacks Rank #2 (Buy) rating, making it a compelling investment opportunity despite the typical challenges dividend stocks face during rising interest rate periods.

In a comparison of two Medical-Products sector stocks, Phibro Animal Health (PAHC) emerges as the superior value investment option compared to LeMaitre Vascular (LMAT). PAHC holds a Zacks Rank of #2 (Buy) with a Value grade of A, featuring a forward P/E of 11.20 and PEG ratio of 1.13. LMAT, rated #4 (Sell) with a Value grade of D, has a forward P/E of 28.10 and PEG ratio of 2.34, indicating it is relatively overvalued.

A comparison of Hewlett Packard Enterprise (HPE) and Advanced Micro Devices (AMD) for value investors reveals that HPE is the more attractive option. HPE has a Zacks Rank of #2 (Buy) with improving earnings outlook, a forward P/E of 14.78, and a Value grade of B. AMD has a Zacks Rank of #3 (Hold) with a forward P/E of 61.38 and a Value grade of F, making it significantly more expensive on traditional valuation metrics.

In a comparison of two Manufacturing - Farm Equipment sector stocks, Kubota Corp. (KUBTY) emerges as the superior value option over Deere (DE). KUBTY holds a Zacks Rank #2 (Buy) with stronger earnings estimate revisions, while DE has a Zacks Rank #3 (Hold). KUBTY's valuation metrics are significantly more attractive, featuring a forward P/E of 12.03 versus DE's 37.31, a PEG ratio of 1.20 compared to DE's 2.79, and a P/B ratio of 1.12 versus DE's 6.51, earning KUBTY an A Value grade against DE's F grade.

A comparison of Target (TGT) and Costco (COST) in the retail discount stores sector reveals that Target presents a better value opportunity. Target has a Zacks Rank of #2 (Buy) with improving earnings outlook, a forward P/E of 15.72, and a Value grade of B. Costco, with a Zacks Rank of #3 (Hold), has a higher forward P/E of 41.75 and a Value grade of D, making it less attractive for value investors.

A comparison of two building products companies shows that Owens Corning (OC) is the superior value option compared to Installed Building Products (IBP). Both stocks hold a Zacks Rank #2 (Buy) with positive earnings outlooks, but OC has significantly better valuation metrics including a lower forward P/E ratio (13.51 vs 22.36), lower PEG ratio (2.01 vs 4.12), and lower P/B ratio (2.82 vs 9.73), earning it a Value grade of A versus IBP's C grade.

Affiliated Managers Group (AMG) and BlackRock (BLK) are compared as potential value investments in the Financial - Investment Management sector. AMG holds a stronger Zacks Rank #2 (Buy) versus BLK's #3 (Hold), with superior valuation metrics including a lower forward P/E ratio of 9.83 compared to BLK's 20.19, and a better Value grade of B versus D. AMG is identified as the more attractive value opportunity based on improving earnings outlook and fundamental metrics.

A comparison of two Electronics - Miscellaneous Products stocks, MKS (MKSI) and Hoya Corp. (HOCPY), both holding a Zacks Rank #2 (Buy). MKSI is identified as the superior value opportunity with a forward P/E of 18.85 and PEG ratio of 0.52, earning a Value grade of B. HOCPY has a higher forward P/E of 29.93 and PEG ratio of 3.27, receiving a Value grade of D.

A comparison of two Manufacturing-Electronics stocks reveals that EnerSys (ENS) presents a better value opportunity than ABB (ABBNY) for value investors. ENS has a stronger Zacks Rank (#2 Buy vs #3 Hold), lower valuation multiples (P/E of 13.51 vs 25.28, PEG of 0.90 vs 1.41), and a superior Value grade (A vs D).

A comparison of Federal Signal (FSS) and Tesla (TSLA) as value investment options reveals FSS as the more attractive choice. FSS holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 21.95 and PEG ratio of 1.57. Tesla carries a Zacks Rank #4 (Sell) with a Value grade of D, boasting a forward P/E of 198.73 and PEG ratio of 8.80, indicating significantly higher valuations.

In a comparison of two Aerospace-Defense sector stocks, General Dynamics (GD) emerges as the superior value investment option compared to Howmet (HWM). Both stocks hold a Zacks Rank #2 (Buy) with positive earnings outlooks, but GD's significantly lower valuation metrics make it more attractive to value investors. GD has a forward P/E of 21.83 versus HWM's 48.46, and a P/B ratio of 3.73 compared to HWM's 17.79, earning GD a Value grade of B while HWM receives an F.

Vertex Pharmaceuticals reported Q2 2026 earnings that missed EPS estimates ($4.73 vs $4.79 consensus) but beat revenue expectations ($3.33B vs $3.23B consensus). The company raised full-year 2026 revenue guidance to $13.10-$13.20B. However, analyst estimates have trended downward over the past month despite the stock gaining 14.4%. The company received a Zacks Rank #3 (Hold) rating with a VGM Score of D, suggesting in-line returns ahead.

Vornado Realty Trust reported Q2 2026 FFO of 67 cents per share, beating consensus estimates by 17.54% with 19.6% year-over-year growth driven by rent commencements and same-store NOI growth. However, revenues missed expectations at $462.2 million versus $472.4 million consensus. The company showed strong New York office leasing activity and completed a $1.1 billion acquisition of a 49% interest in Park Avenue Plaza. Despite positive earnings, shares have underperformed the S&P 500 by 10.4% since the last earnings report, and the stock carries a Zacks Rank #3 (Hold) rating.

Viper Energy Partners (VNOM) reported Q2 2026 earnings of 76 cents per share, beating consensus estimates by 4.1%, driven by 69.5% production growth and 35.3% higher realized oil prices. The company raised its 2026 production guidance and increased its annualized base dividend by 32% to $2 per share. Shares have gained 7.2% in the past month, outperforming the S&P 500.

AMD is shifting its AI strategy toward inference with potential growth drivers including Helios, Instinct systems, high-bandwidth memory, and improved software. However, the company's premium valuation creates high execution pressure. Success depends on inference becoming a major profit engine and converting deployments into sustained earnings growth.

The global battery simulation software market is projected to grow from $1.60 billion in 2025 to $5.38 billion by 2035, driven by rising EV adoption and advanced battery development. Lithium-ion batteries dominate with 53% market share, while North America leads regionally at 37.4% share. Key growth drivers include increasing demand for precise battery modeling, thermal simulation optimization, and R&D investments in next-generation batteries.

While Wall Street analysts show strong bullish sentiment on Cipher Digital Inc. (CIFR) with an average brokerage recommendation of 1.22 (Strong Buy/Buy), the article cautions investors against relying solely on these recommendations. The company's Zacks Rank has been downgraded to #4 (Sell) due to a 70.8% decline in consensus earnings estimates over the past month, indicating analyst pessimism about the company's earnings prospects despite positive broker ratings.

While Wall Street analysts show strong bullish sentiment on PPL with an average brokerage recommendation of 1.43 (Strong Buy), the article cautions that brokerage recommendations often have positive bias due to institutional conflicts of interest. The Zacks Rank system, which relies on earnings estimate revisions, rates PPL as a Hold (#3) with unchanged consensus earnings estimates of $1.94 for the current year, suggesting the stock may perform in line with the broader market.

While brokers give Broadcom Inc. (AVGO) a strong buy recommendation with an average brokerage rating of 1.35, the article cautions that brokerage recommendations are often overly optimistic due to vested interests. The Zacks Rank system, which relies on earnings estimate revisions, rates AVGO as a Hold (#3), suggesting investors should be cautious despite the positive broker sentiment. The company's consensus earnings estimate has remained unchanged over the past month.

Solventum Corporation (SOLV), a healthcare company spun off from 3M, has been added to the Zacks Focus List. The stock has gained 31.53% since its April 2024 IPO at $69.15, now trading at $90.95. Six analysts raised earnings estimates in the last 60 days, with consensus estimates increasing $0.55 to $7.13 for fiscal 2026. The company is expected to deliver 16.7% earnings growth for the current fiscal year and has demonstrated a 13.2% average earnings surprise.

Visa is expanding its presence in the growing account-to-account (A2A) payments market with an enhanced A2A Protect solution that uses AI to detect fraud in real-time. The solution boosts scam detection by up to 75% and reduces false alerts by 40%, allowing Visa to monetize A2A transactions even when they bypass its traditional card network. This supports Visa's Value-Added Services growth strategy and deepens relationships with financial institutions.

A $1,000 investment in Visa stock at its 2008 IPO would be worth approximately $440,000 today, including reinvested dividends. Visa's exceptional business model, dominant market position as the world's largest credit card network, asset-light operations, and consistent dividend growth over 18 years demonstrate its reliability as a long-term investment that benefits from economic expansion.

Joshua Foster, SVP and General Counsel of Resideo Technologies, purchased 15,317 shares worth approximately $315,000 at a weighted average price of $20.58 per share on August 14, 2026. The insider purchase signals confidence in the company following its recent spin-off of ADI Global Distribution, positioning Resideo as a pure-play smart home and building automation company. Despite the stock declining 17.6% over the past year, analysts remain bullish with a median price target of $30.65, suggesting potential 59% upside.

The article explains why EV-to-EBITDA is a superior valuation metric compared to P/E ratios, as it accounts for debt and provides a more complete picture of company value. Five stocks meeting strict screening criteria—Par Pacific Holdings, Amkor Technology, Kohl's, Avnet, and Ecovyst—are highlighted as attractive bargain stocks with low EV-to-EBITDA multiples and strong growth prospects.

Renk Group AG issued a regulatory disclosure according to Article 40 (1) of the German Securities Trading Act (WpHG) regarding shareholder information. The disclosure confirms that the reporting party neither controls nor is controlled by other companies holding voting rights in the issuer, and provides information on the complete chain of subsidiaries.

NordVPN has partnered with Klarna to provide VPN and cybersecurity services as included benefits across Klarna's membership tiers. Klarna Premium members receive NordVPN Basic, while Klarna Max members get NordVPN Standard at no additional cost. Lower-tier members receive free trial periods. The partnership integrates online privacy protection into Klarna's existing ecosystem of financial, travel, and lifestyle rewards.

AIM ImmunoTech announced patent protection for Ampligen across 18 European countries and the United Kingdom through June 2041 for Long COVID treatment. The company also recently secured a U.S. patent for Ampligen combined with pembrolizumab for cancer treatment. These patents strengthen AIM's global intellectual property position around its dsRNA immunomodulator platform across multiple therapeutic indications.